Latest United Kingdom Startup Funding Rounds
Startup funding in United Kingdom: recent rounds, the companies behind them and their participating investors.
- Rounds
- 427 Jan 1 – Oct 23, 2026
- Disclosed funding
- $22.9B 355 disclosed amounts
- Median round
- $9.3M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B BidScriptCompany profile AI-native tender management platform for public and private sector contracts AI-native tender management platform for public and private sector contracts | $800K | Pre-SeedPre-seed | Proptech | United Kingdom | Investors | |
| S StirlingXCompany profile Develops secure data intelligence systems for defence and critical infrastructure Develops secure data intelligence systems for defence and critical infrastructure | $20M | Series A | Defense tech | United Kingdom | Investors | |
| M MDOTMCompany profile Provides AI-driven investment solutions for asset and wealth management companies Provides AI-driven investment solutions for asset and wealth management companies | $27M | Growth | Fintech | United Kingdom | Investors | |
| G GaussionCompany profile Gaussion develops magnetic-field control technology to improve lithium-ion battery performance. Gaussion develops magnetic-field control technology to improve lithium-ion battery performance. | $28M | Funding roundUndisclosed | Climate tech | United Kingdom | Investors | |
| L Develops lab plastic recycling system | £430K | Seed | Climate tech | United Kingdom | Investors | |
| RB RQ BioCompany profile Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients | $115M | Series A | Biotech | United Kingdom | Investors | |
| TT TRIMTECH TherapeuticsCompany profile Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases | $47M | Seed+Seed | Biotech | United Kingdom | Investors | |
| AS Astral SystemsCompany profile Develops multi-state fusion technology for medical radioisotopes and commercial applications Develops multi-state fusion technology for medical radioisotopes and commercial applications | £23M | Series A | Industrial tech | United Kingdom | Investors | |
| S Manufactures commercial electric vehicles for middle mile logistics | $21M | Series A | Mobility | United Kingdom | Investors | |
| FH Develops AI agents for NHS administrative tasks. | £9.7M | Seed | Healthtech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Innovate UK
Emerald, Go Eve, Affinity Labs
17rounds0led - 2British Business Bank
Microbiotica, OMass Therapeutics, Salience Labs
16rounds2led - 3NVIDIA
Riverlane, Foresight, Hiverge
12rounds0led - 4Entrepreneurs First
Opply, Scarlet, Open Cosmos
11rounds0led - 5Octopus Ventures
Metris Energy, Resolutiion, Ossprey
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.